
Alavita Pharmaceuticals Inc.: Innovating in drug industry to reduce organ transplant failure.
Alavita Pharmaceuticals Inc. was founded with a core mission to innovate within the drug industry by developing products aimed at reducing organ transplant failure. The company focuses on researching and manufacturing pharmaceutical solutions that address critical needs in the transplant medicine market. Their vision is to significantly improve patient outcomes and enhance the quality of life for transplant recipients through cutting-edge medical advancements.
Notable affiliated individuals and investors include leading experts in transplant medicine and biotechnology, though specific names are not provided. Key achievements include the development of groundbreaking drugs that have shown promise in reducing organ rejection rates. Alavita Pharmaceuticals has made a substantial impact in the medical community by offering hope and improved health prospects to organ transplant patients worldwide.
Aliva Biopharmaceuticals

Aquavit Pharmaceuticals
aquavitpharma.com

Avalyn Pharma
avalynpharma.com

Aviv Pharma

Alphavax
alphavax.com

Aria Pharmaceuticals

Navitor Pharmaceuticals

Aivita Biomedical

Avalo Therapeutics
avalotx.com

iQure Pharma
iqurepharma.com

Alimera Sciences

Aldea Pharmaceuticals

Novita Pharmaceuticals
novita-pharm.com

Thar Pharmaceuticals
tharpharma.com

Bayer Pharmaceuticals
bayer.com
Companies similar to Alavita Pharmaceuticals include Aliva Biopharmaceuticals, Aquavit Pharmaceuticals, Avalyn Pharma and Aviv Pharma.
Alavita Pharmaceuticals was founded in 2005.
Alavita Pharmaceuticals' headquarters is located in Mountain View, CA, US.
Alavita Pharmaceuticals' most recent funding round was for $600k (USD) in September 2009.
As of Sep 21, 2009, Alavita Pharmaceuticals has raised a total of $600k (USD).
Alavita Pharmaceuticals has 5 employees as of Feb 5, 2024.